Next generation sequencing has revolutionized disease diagnosis by providing expression profiles of disease phenotypes compared to healthy controls. The current study was intended to profile the transcriptome of immunologically categorized TB phenotypes compared to healthy controls and TB-cured individuals. Methodology: RNA samples from eight individuals including duplicates of each phenotype underwent whole transcriptome sequencing utilizing the Illumina platform. The raw data after normalization was mapped onto the hg-19 reference human genome. Differential expression analysis of the four phenotypes in six pairwise comparisons was carried out on the FPKM values using DESeq2 Bioconductor package and finally GO ontology and KEGG pathway analysis was done using phyper package in R. Results: The transcriptome sequencing resulted in 3351 differentially expressed genes (DEGs) (fold change (FC) = 2 and adj. p-value=0.001) comprising 2248 upregulated and 1103 downregulated genes among all comparisons. The highest number of DEGs were obtained between the TB-CU vs. HC pair (n=1066) and the lowest number of DEGs were obtained between the ATB vs. HC pair (n=76). Interestingly, most of the genes in ATB vs. HC were downregulated leading to an active disease state. Similarly, comparatively more genes in the TB-CU vs. HC pair were also downregulated. However, in LTBI vs. HC, the majority of the genes were upregulated which might reflect the activation of pathways leading to latency. Pathway analysis revealed the enrichment of many important pathways like antigen processing and presentation, Wnt signaling pathway and mTOR signaling pathway. Conclusion: The transcriptome analysis revealed significant dysregulation of gene expression patterns across different TB phenotypes compared to HC suggesting a distinct molecular signature associated with TB-CU phenotype. Future follow-up studies of the TB phenotypes with a larger patient cohort would be needed to strengthen the findings of this study.